• Researcher in cancer and immunopathology, CHUM Research Centre
  • Research member at the Montreal Cancer Institute
  • Professor under grant in the Department of Microbiology, Infectious Diseases and Immunology of the Faculty of Medicine of the Université de Montréal

Research Angle

Our work focuses on the use of so-called oncolytic viruses for the treatment of cancer. Specifically, we are genetically modifying viruses to improve their therapeutic efficacy, studying the factors in the tumor microenvironment that determine susceptibility, and also using these same viruses as a platform for the creation of cancer vaccines. Focus: breast cancer, leukemia and ovarian cancer.

Laboratory Team

  • Victor Mullins-Dansereau ; PhD student
  • Karen Geoffroy ; PhD student
  • Delphine Béland ; PhD student
  • Stamatios Paradisis ; master student
  • Bruna Araripe Saraiva ; Research intern

LinkedIn Profile

Marie-Claude Bourgeois-Daigneault

Recent Publications

  1. https://pubmed.ncbi.nlm.nih.gov/32694051/
  2. https://pubmed.ncbi.nlm.nih.gov/32248971/
  3. https://pubmed.ncbi.nlm.nih.gov/31646102/
  4. https://pubmed.ncbi.nlm.nih.gov/30755678/
  5. https://pubmed.ncbi.nlm.nih.gov/29298865/

Pubmed Page


Email address for application



Graduated with a doctorate in Microbiology and Immunology from the Université de Montréal, I completed a postdoctoral fellowship on viral therapy of cancer at the Ottawa Hospital Research Institute before returning to Montreal to open my research laboratory at the CHUM Research Center in 2018.